Neuroactive steroids with perfluorobenzoyl group

被引:4
|
作者
Cerny, Ivan [1 ]
Budesinsky, Milos [1 ]
Pouzar, Vladimir [1 ]
Vyklicky, Vojtech [2 ,3 ]
Krausova, Barbora [2 ]
Vyklicky, Ladislav, Jr. [2 ]
机构
[1] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague 6, Czech Republic
[2] Acad Sci Czech Republic, Inst Physiol, Vvi, CR-14220 Prague, Czech Republic
[3] Charles Univ Prague, Fac Med 2, Prague 15006, Czech Republic
关键词
Neuroactive steroids; Synthesis; Perfluorobenzoates; NMDA receptor; PERFLUOROPHENYL AZIDES; GABA(A) RECEPTORS; DERIVATIVES; INVERSION; INHIBITOR; ANALOGS;
D O I
10.1016/j.steroids.2012.07.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During an initial study in searching for the alternative derivatives suitable for photolabeling of neuroactive steroids, perfluorobenzoates and perfluorobenzamides in position 17 of 5 beta-androstan-3 alpha-ol were synthesized from the corresponding 17-hydroxy and 17-amino derivatives. After transformation into glutamates or sulfates, 17 alpha-epimers had comparable inhibitory activity at NMDA receptors to the natural neurosteroid (20-oxo-5 beta-pregnan-3 beta-yl sulfate), however, were more potent (2- to 36-fold) than their 17 beta-substituted analogs. In one case, fluorine in position 4' of perfluorobenzoate group was substituted with azide and activity of the final glutamate was retained comparing with the corresponding perfluorobenzoate. The series was expanded with perfluorobenzoyl derivatives of pregnanolone: Perfluorobenzamide of glutamate and perfluorobenzoate of 11 alpha-hydroxy pregnanolone were prepared and tested. From nine tested compounds, four of them exhibit very good inhibition activity and can serve as promising leads for photolabeling experiments. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1233 / 1241
页数:9
相关论文
共 50 条
  • [1] NEUROACTIVE STEROIDS
    PAUL, SM
    BIOLOGICAL PSYCHIATRY, 1993, 33 (6A) : A70 - A70
  • [2] NEUROACTIVE STEROIDS
    PAUL, SM
    PURDY, RH
    FASEB JOURNAL, 1992, 6 (06): : 2311 - 2322
  • [3] NEUROACTIVE STEROIDS
    PAUL, SM
    NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) : S21 - S21
  • [4] Neuroactive steroids
    Paul, SM
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 11 - 11
  • [5] Steroids, neuroactive steroids and neurosteroids in psychopathology
    Dubrovsky, BO
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (02): : 169 - 192
  • [6] Neuroactive steroids in neuropsychopharmacology
    Rupprecht, R
    Holsboer, F
    NEUROSTEROIDS AND BRAIN FUNCTION, 2001, 46 : 461 - 477
  • [7] Neuroactive steroids in schizophrenia
    Shulman, Y
    Tibbo, PG
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (11): : 695 - 702
  • [8] Neuroactive steroids and ethanol
    Purdy, RH
    Valenzuela, CF
    Janak, PH
    Finn, DA
    Biggio, G
    Bäckström, T
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (07) : 1292 - 1298
  • [9] Stress and neuroactive steroids
    Barbaccia, ML
    Serra, M
    Purdy, RH
    Biggio, G
    NEUROSTEROIDS AND BRAIN FUNCTION, 2001, 46 : 243 - 272
  • [10] Neuroactive steroids and metabolic axis
    Melcangi, R. C.
    Panzica, G. C.
    FRONTIERS IN NEUROENDOCRINOLOGY, 2018, 48 : 1 - 2